Search PubMed⌕ Search

Biomedical subjects

H A Oberman

Publications and source records attributed to H A Oberman.

At least 37 records · Page 2Linked to original sources
PubMed1995

Pure and mixed mucinous carcinoma of the breast: pathologic basis for differences in mammographic appearance.

OBJECTIVE: It is important to differentiate pure and mixed mucinous carcinomas of the breast because the former have a more favorable prognosis. We correlate histopathologic findings with mammographic findings for 20 patients with pure or mixed mucinous carcinomas to determine differential characteristics and their pathologic basis. MATERIALS AND METHODS: We searched our pathology database of 2219 consecutive women with a diagnosis of breast cancer and found that 31 (1.4%) had mucinous carcinomas. Eleven women were excluded because the mammograms (n = 6) or the microscopic slides (n = 5) were not available. The remaining 20 women, who were 37-92 years old (mean, 64 years), were the subjects of the study. Their clinical records, mammograms, and microscopic slides were reviewed. Tumor size was based on the maximum mammographic diameter or measured diameter of the excised tumor. RESULTS: Seventeen patients (85%) had tumors that were mammographically apparent. Histopathologic review confirmed 15 pure mucinous tumors and five mixed mucinous tumors having an overall mean diameter of 3.4 cm. The pure-tumor group contained three incidentally detected tumors (all < or = 0.8 cm in diameter); six that had a circumscribed, lobular contour on mammograms (mean diameter, 3.6 cm); and six that had a poorly defined, irregular contour (mean diameter, 1.2 cm). One of the mammographically apparent small pure tumors contained histologically confirmed psammomatous microcalcifications. All pure tumors had microscopically evident circumscribed margins that could have accounted for the circumscribed mammographic appearance of the larger masses. All mixed tumors had mammographically and histologically evident irregular margins because of the associated fibrosis and infiltrative margins of the nonmucinous component (mean diameter, 5.3 cm). CONCLUSION: There are differences in the mammographic appearances of pure and mixed mucinous carcinomas that have a histopathologic basis. Circumscribed, lobular margins on mammograms are characteristic of large pure tumors and are the result of their microscopically evident circumscribed margins and expansile growth pattern. Irregular margins on mammograms are more characteristic of mixed mucinous tumors, regardless of tumor size, and are attributable to the fibrotic and infiltrative nature of the nonmucinous component.

Adenocarcinoma, Mucinous↗
PubMed1994

Electronic verification of donor-recipient compatibility: the computer crossmatch.

BACKGROUND: This article describes standard operating procedures (SOPs) for a computer crossmatch to replace the immediate-spin crossmatch for ABO incompatibility between patient blood samples submitted for pretransfusion testing and the blood component selected for transfusion. These SOPs were developed following recent changes to the Standards for Blood Banks and Transfusion Services of the American Association of Blood Banks (AABB). STUDY DESIGN AND METHODS: SOPs were developed, utilizing currently available software, for pretransfusion testing. The SOP for donor unit processing entails bar code entry of the unit number, component name, and ABO/Rh type; computer entry and interpretation of serologic reactions; warning of discrepancies between bar code-entered blood type and result interpretation; and quarantine of the donor unit in such instances. The SOP for patient sample testing requires bar code entry of specimen accession number, which accesses patient demographics; computer entry and interpretation of ABO/Rh tests; repeat blood typing at the time of crossmatch if only one patient blood type is on record; and warning if there are nonconcordant current and historical blood types. The computer crossmatch SOP requires bar code entry of specimen accession and donor unit numbers; release of group O red cells pending resolution of discrepancies; and immediate-spin crossmatch during computer downtime. Tables validated on-site prompt warning messages and prevent both computer crossmatch and release if blood components of the wrong ABO type are selected. RESULTS: These SOPs meet the requirements of the 15th edition of the AABB Standards. Projected annual time savings at this institution are > 100,000 workload recording units. Further benefits include reduced patient sample volume requirements, less handling of biohazardous material, and elimination of unwanted positive or negative reactions associated with the immediate-spin crossmatch. Release of incompatible blood components when the wrong patient blood type is on record is addressed by requiring the use of group O red cells in the absence of two concordant blood types, one of which must be from a current sample. CONCLUSION: A combination of existing computer programs and carefully developed SOPs can provide a safe and efficient means of detecting donor-recipient incompatibility without performance of serologic crossmatch.

ABO Blood-Group System↗
PubMed1993

Invasive lobular carcinoma. Imaging features and clinical detection.

RATIONALE AND OBJECTIVES: Mammographic findings and method of detection of 52 cases of invasive lobular carcinoma (ILC), the second most common breast carcinoma, are reported. METHODS: Preoperative mammograms and clinical records of all patients with ILC not associated with a second mammary carcinoma (other than lobular carcinoma in situ) from 1979-1991 at the authors' institution were retrospectively reviewed. RESULTS: Abnormal mammographic findings were present in 48/52 (92%) and included irregular spiculated masses (33/52, 63%), asymmetric densities (7/52, 13%), architectural distortion (5/52, 10%), microcalcifications (2/52, 4%), and well circumscribed masses (1/52, 2%). The mean mammographic diameter was 2.1 cm. The tumor was most often best visualized in the craniocaudal projection. At the time of diagnosis, 54% of women had coexistent suggestive breast physical findings and 35% had metastatic carcinoma in axillary lymph nodes. CONCLUSIONS: The infrequency of microcalcifications in pure ILC may hinder mammographic detection and contrasts markedly with ductal carcinoma. Mammography and breast physical examination play complementary roles in the detection of ILC.

Adult↗
PubMed1992

Can the reading for serologic reactivity following 37 degrees C incubation be omitted?

The need to detect antibodies that agglutinate and/or hemolyze red cells (RBCs) directly at 37 degrees C, but do not react in subsequently performed indirect antiglobulin tests (IATs), is of concern relative to the streamlining and automation of antibody detection methods. To determine incidence and significance of such reactions, data from 87,480 tests, which used low-ionic-strength saline, 10-minute incubation at 37 degrees C, and anti-IgG, were analyzed for unexpected antibodies. There were 3590 positive tests, of which 475 showed reactions at 37 degrees C but not in subsequently performed IATs (37 + IAT-). Of these, 196 reactions were due to autoantibodies or other factors usually considered insignificant with respect to the survival of transfused incompatible RBCs, 176 were due to alloantibodies of questionable clinical significance (M, Lea, P1, etc.), and 103 were associated with alloantibodies of potential clinical significance (63 E, 27 K, 5 Jka, 4 D, 3 cE, and 1 C). This latter reaction was seen in 72 patients, with two 37 + IAT-antibodies occurring in each of 3 patients. Of the 75 potentially significant 37 + IAT-antibodies, 57 were seen in patients recently exposed to homologous RBCs, 13 in patients with a history of transfusion and/or pregnancy, and 5 in patients with no known exposure to homologous RBCs. IAT reactivity was observed in subsequent samples with 27 of these antibodies. The predictive value of a 37 + IAT-test was 21.7 percent for a potentially significant antibody. The incidence was 0.12 percent of all tests for unexpected antibodies.(ABSTRACT TRUNCATED AT 250 WORDS)

Blood Group Antigens↗
PubMed1991

Noninvasive carcinoma of the breast presenting in adenosis.

Although sclerosing adenosis is a common abnormality in the female breast, malignant change presenting in this setting is exceedingly rare, as fewer than 20 cases have been reported. Since sclerosing adenosis is a lesion of the mammary lobule, it is not surprising that the majority of reported cases have been lobular carcinoma in situ (LCIS). Nine patients with noninvasive carcinoma, restricted in the initial biopsy specimen to foci of sclerosing adenosis, are reported. Seven of the patients had LCIS, one had intraductal carcinoma (DCIS), and one had both LCIS and DCIS. In six of the nine patients, the carcinoma was an incidental finding in a breast biopsy performed for fibrocystic changes or for a fibroadenoma, and in three patients, the abnormality presented as a grossly discrete lesion due to confluence of foci of adenosis (tumoral adenosis). It is important to recognize this microscopic pattern of neoplasia to prevent its misdiagnosis as invasive carcinoma. Two patients had no further treatment following initial excisional biopsy. No residual carcinoma was found in the breast or in lymph nodes in the four patients who had mastectomy. Eight of these patients have been followed for an average of 3 yr (range, 2 to 7 yr), and all are alive and well, without recurrence. Because of the possibility of multifocality, the rarity of the lesion, and the relatively brief follow-up interval, it seems prudent to treat these patients in a manner comparable to that of patients with more common presentations of noninvasive carcinoma.

Adult↗
PubMed1990

Percutaneous umbilical blood sampling and umbilical vein transfusions. Rapid serologic differentiation of fetal blood from maternal blood.

Percutaneous umbilical blood samples (PUBS), obtained under ultrasound guidance, are used for prenatal diagnosis and management of hemolytic disease of the newborn (HDN) and other fetal disorders. Rapid testing at the time of sampling is vital to distinguish fetal from maternal blood. Blood typing was performed by slide technique in the treatment room during 38 procedures on 25 patients. Anti-I was used to test 50 presumed PUBS; venous I-positive maternal blood was tested in parallel. Because anti-I cannot detect fetal blood after umbilical vein transfusion (UVT) of I-positive donor blood, ABO and Rh blood typing reagents were used to test 29 samples when maternal and fetal or donor blood groups differed. Monoclonal reagents were used for optimal detection of weak AB antigens in fetal blood. Avid, chemically modified anti-D was used for Rh typing. Blood typing showed 27 (34%) of 79 samples to be maternal blood. Fetal blood was obtained in 8 of 10 cases investigated for fetal disorder and in 16 cases of potential HDN (anti-D, 5; -CD, 5; -cE, 2; -K, 2; -c; -E). The absence of HDN (antigen-negative fetus) was determined in 4 cases. UVT afforded live birth of 9 of 10 infants with HDN and was not indicated in two cases.

Blood Grouping and Crossmatching↗
PubMed1990

Blood use during extracorporeal membrane oxygenation.

An analysis of the transfusion records of 91 neonatal patients subjected to extracorporeal membrane oxygenation (ECMO) is reported. Mean daily blood usage was 250 mL of red cells (RBCs), 80 mL of fresh-frozen plasma, and 2 units of platelets. Average time on ECMO was 4.6 days. Group O or ABO type-specific RBCs and group AB or ABO type-specific plasma products and platelets were transfused. RBCs were not washed, and neither RBCs nor other components were tested for anticytomegalovirus (CMV) or irradiated. No cases of posttransfusion CMV infection or graft-versus-host disease were observed. Hemolysis in eight patients was traced to occlusions in the ECMO circuit. All but three patients survived ECMO. Contrary to a previous report, an active ECMO program for neonatal patients imposes a minimal burden on the hospital transfusion service.

Bilirubin↗
PubMed1990

Radial sclerosing lesion of the breast: mammographic features.

The authors present the clinical, mammographic, and pathologic findings in seven patients with radial sclerosing lesions (RSLs) who had a nonpalpable stellate lesion at mammography. Although the radiographic findings were suggestive of RSL in six of seven patients, diagnostic excisional biopsy was recommended for all. One RSL had associated microcalcifications localized in contiguous adenosis. The authors did not find this a useful criterion to differentiate RSL from carcinoma. Similarly, the presence of either a lucent or dense central core was not radiographically diagnostic. Surgical excision of these stellate lesions is therefore required.

Breast↗
PubMed1989

Breast hamartomas: variable mammographic appearance.

The mammograms of 17 women with pathologically proved breast hamartomas were reviewed. Abnormal masses were detected on 12. Nine women had masses with benign features. Two of these had findings considered classic for hamartoma. In three cases, the appearance of the mass was suggestive of carcinoma. The breasts were very dense in four of five women without detectable mass. The findings suggest that the classic mammographic appearance of breast hamartomas is less common than previously reported, which may be explained by earlier detection of small hamartomas.

Adult↗
PubMed1989

Paraffin tissue block radiography: adjunct to breast specimen radiography.

Radiography of specimens is an essential step in confirming excision of nonpalpable breast lesions. On occasion, however, the pathologist may not identify the lesion histologically. The authors report five cases in which suspicious microcalcifications were included in the excised tissue but were not identified by the pathologist. In all five, paraffin tissue block radiography enabled identification of the specific blocks containing the microcalcifications. The correct tissue blocks were then sectioned again, and the microcalcifications were identified histopathologically. In one case, the initial diagnosis of intraductal hyperplasia was changed to intraductal carcinoma with focal invasion. When the pathologist cannot identify the calcifications on initial histopathologic sections, this technique may assist in identification of the mammographic abnormality.

Biopsy↗